Oral Liquid Formulation of Levothyroxine Is Stable in Breakfast Beverages and May Improve Thyroid Patient Compliance

• Egile Nagusiak: Alberto Bernareggi (Egilea), Elia Grata (Egilea), Maria Teresa Pinorini (Egilea), Ario Conti (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2013-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Patients on treatment with levothyroxine (T4) are informed to take this drug in the morning, at least 30 min before having breakfast. A significant decrease of T4 absorption was reported, in fact, when T4 solid formulations are taken with food or coffee. According to preliminary clinical study repor...